申请人:ASTELLA PHARMA INC.
公开号:US20160031847A1
公开(公告)日:2016-02-04
[Problem]To provide a compound which is useful as an agent for preventing and/or treating kidney diseases.
[Means for Solution]The present inventors have studied compounds having a trypsin inhibitory activity, and have confirmed that a guanidinobenzoic acid ester compound has a trypsin inhibitory activity, thereby completing the present invention. The guanidinobenzoic acid ester compound of the present invention can be used as an agent for preventing and/or treating kidney diseases (for example, chronic kidney disease, acute glomerulonephritis, acute kidney injury, and the like) as an agent which will substitute low-protein diet therapy, and/or as an agent for preventing and/or treating trypsin-related diseases (for example, chronic pancreatitis, gastroesophageal reflux disease, hepatic encephalopathy, influenza, and the like).
提供一种可用作预防和/或治疗肾脏疾病的化合物。现发明人研究了具有胰蛋白酶抑制活性的化合物,并确认一种鸟氨酸苯甲酸酯化合物具有胰蛋白酶抑制活性,从而完成了本发明。本发明的鸟氨酸苯甲酸酯化合物可用作预防和/或治疗肾脏疾病的药剂(例如,慢性肾病、急性肾小球肾炎、急性肾损伤等),作为替代低蛋白饮食疗法的药剂,和/或作为预防和/或治疗与胰蛋白酶相关疾病的药剂(例如,慢性胰腺炎、胃食管反流病、肝性脑病、流感等)。